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Abstract
Intrauterine growth restriction (IUGR) is a risk factor for cardiovascular disease in later life. Early structural and functional
changes in the cardiovascular system after IUGR may contribute to its pathogenesis. We tested the hypothesis that IUGR
leads to primary myocardial and vascular alterations before the onset of hypertension. A rat IUGR model of maternal protein
restriction during gestation was used. Dams were fed low protein (LP; casein 8.4%) or isocaloric normal protein diet (NP;
casein 17.2%). The offspring was reduced to six males per litter. Immunohistochemical and real-time PCR analyses were
performed in myocardial and vascular tissue of neonates and animals at day 70 of life. In the aortas of newborn IUGR rats
expression of connective tissue growth factor (CTGF) was induced 3.2-fold. At day 70 of life, the expression of collagen I was
increased 5.6-fold in aortas of IUGR rats. In the hearts of neonate IUGR rats, cell proliferation was more prominent compared
to controls. At day 70 the expression of osteopontin was induced 7.2-fold. A 3- to 7-fold increase in the expression of the
profibrotic cytokines TGF-b and CTGF as well as of microfibrillar matrix molecules was observed. The myocardial expression
and deposition of collagens was more prominent in IUGR animals compared to controls at day 70. In the low-protein diet
model, IUGR leads to changes in the expression patterns of profibrotic genes and discrete structural abnormalities of vessels
and hearts in adolescence, but, with the exception of CTGF, not as early as at the time of birth. Invasive and non-invasive
blood pressure measurements confirmed that IUGR rats were normotensive at the time point investigated and that the
changes observed occurred independently of an increased blood pressure. Hence, altered matrix composition of the
vascular wall and the myocardium may predispose IUGR animals to cardiovascular disease later in life.
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Introduction
Cardiovascular events like stroke or myocardial infarction are
among the leading factors of morbidity and mortality in the
western worId. These diseases are the consequence of atheroscle-
rosis which in turn is often brought about by multiple risk factors.
Numerous epidemiologic and animal studies prove that
intrauterine growth restriction (IUGR), which affects about 5–
10% of all newborns, is an important risk factor for the
development of the metabolic syndrome later in life [1]. In former
IUGR individuals, type 2 diabetes, hypertension and hyperlipide-
mia occur more frequently than in individuals with normal birth
weight [1,2]. Two recent clinical studies by Crispi et al. [3,4]
provided evidence that in humans IUGR results in early fetal signs
of cardiac dysfunction and manifest cardiovascular changes
already in childhood. Moreover, a direct correlation between
low birth weight and atherosclerosis later in life could be
demonstrated [5]. As a consequence a higher incidence of
coronary heart disease is described in former IUGR patients [6].
Studying the aetiopathogenetic interrelation between the fetal and
neonatal problem of IUGR and cardiovascular diseases at
adulthood, Barker and colleagues created the term of ‘‘fetal
programming’’. They postulated that fetal adaptation to an
adverse intrauterine environment modifies cellular differentiation
and tissue structure permanently and thus impairs cardiovascular
structure, function and integrity [6,7]. In this context it could be
shown in animal studies, that IUGR associated intrauterine
hypoxia leads to an altered myocardial vasculature which causes a
reduced cardial performance and the morphological phenotype of
dilated cardiomyopathy [8,9]. Furthermore it could be shown that
hypoxic intrauterine conditions lead to atherosclerosis in the
offspring [10]. Martyn et al. [11] proposed an unfavourable
relation of collagen to elastin in the walls of large vessels arising in
early fetal development. Several studies in humans confirmed that
a number of early changes in vessel walls are associated with
IUGR [12–14].
In humans, IUGR may be brought about by different factors
such as decreased placental perfusion, or maternal nutritional
deficiencies. To study the pathomechanisms of IUGR and its
association with diseases in later life, a number of animal models of
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20369IUGR were developed [15]. We used the low protein diet model of
IUGR in the rat which is widely used [16–18], because it is easy to
handle and highly reproducible. In the offspring of rats fed on a
low protein diet during gestation, a reduced number of
cardiomyocytes was detected at the time of birth [19]. Later in
life, former growth restricted rats had a higher degree of
myocardial interstitial fibrosis [20]. Maternal low protein diet
reduced aortic wall thickness and elastin content in the offspring at
12 weeks of age [21]. However, it remained unclear, if the
cardiovascular changes observed in these studies are a conse-
quence of increased blood pressure, which is frequently observed
at an older age in this model [15,16,18], or precede the
development of hypertension.
Cardiovascular disease in human develops over decades but
according to the theory of fetal programming its cornerstone is
already laid in childhood. We tested the hypothesis that IUGR in
the low protein diet model results in early changes in the
expression of matrix components and cytokines and thus leads to
alterations in the structure of the heart and blood vessels long
before the onset of cardiovascular disease. A dysregulation of
inflammatory and fibrotic factors is known to contribute to the
development of hypertension, atherosclerosis or cardiac insuffi-
ciency. For this reason, we performed invasive and non-invasive
blood pressure measurements and studied expression patterns of
inflammatory and fibrotic markers in the hearts and aortas of
newborn and adolescent IUGR rats of the low protein diet model
using real-time PCR and immunohistochemistry.
Materials and Methods
Animal procedures
All procedures performed on animals were carried out in
accordance with guidelines of the American Physiological Society,
conform to the Guide for the Care and Use of Laboratory Animals
published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996) and were approved by the
local government authorities (Regierung von Mittelfranken, AZ #
54-2531.31-12/06). Virgin female Wistar rats (220 to 300 g) were
obtained from Charles River (Sulzfeld, Germany) and were
housed in a room maintained at 2262uC, exposed to a 12 hour
dark/light cycle. The animals were allowed unlimited access to
standard chow (#1320, Altromin, Lage, Germany) and tap water.
Ten dams were time-mated by the appearance of sperm plugs and
then fed a diet containing 17.2% casein or an isocaloric diet
containing 8.4% casein throughout pregnancy. Diets were
obtained from Altromin (# C1000, C1003). Sodium content
(0.25%) of both diets was equal. Rats delivered spontaneously and
the litters were reduced to 6 male pups per dam as previously
described [22] to achieve equal lactation conditions. The offspring
of the mothers fed with the 17.2% protein containing diet were
termed NP, the offspring of the mother with protein restriction
were termed LP. Surplus male pups were used for histological and
molecular evaluation of neonatal aortas and hearts. During
lactation, rat mothers were fed standard chow. The offspring
was nursed by their mothers until weaned at day 21 to standard
chow. Rats were killed by retrograde perfusion in deep anesthesia,
applying 100 mg/kg ketamine (Ketavet, Pfizer GmbH) and 5 mg/
kg medetomidin (Domitor, Pfizer GmbH) intraperitoneally. The
offspring used for experiments was derived from at least five litters
in each group. Aortas were collected after removal of the
adventitia. One part of the aortas was immediately snap frozen
in liquid nitrogen for preparation of RNA. Another part was fixed
in methyl carnoy solution and embedded in paraffin. Hearts were
removed and a 3 mm thick most apical part of left ventricular
tissue was snap frozen in liquid nitrogen for preparation of RNA.
Another 3 mm of the adjacent part of left ventricular tissue was
fixed in methyl carnoy solution and embedded in paraffin for
immunohistochemistry. 2 mm sections of fixed tissue were cut with
a Leitz microtome (Leica Instruments, Wetzlar, Germany).
Blood pressure measurements
Blood pressure values were obtained by following methods:
Tail-cuff measurements of systolic blood pressure were per-
formed in trained rats using a non-invasive blood pressure
monitoring system (TSE Technical Scientific Equipment GmbH,
Bad Homburg, Germany) one day before sacrifice. Animal
contacting components were pre-warmed to 30uC and rats were
positioned in the restrainer. After an acclimatization phase of
Table 1. List of primer pairs.
LTBP-1 (Latent TGF- b Binding Protein) forward 59- CGGATCCCCCTATGATCTCA -39
reverse 59- TGACGAGGCGGTAGCAGG -39
CTGF (Connective Tissue Growth Factor) forward 59- TGTGCACTGCCAAAGATGGT -39
reverse 59- GGTACACGGACCCACCGA -39
Fibrillin-1 forward 59- TGCTCTGAAAGGACCCAATGT -39
reverse 59- CGGGACAACAGTATGCGTTATAAC -39
Elastin forward 59- GAAAACCCCCGAAGCCCTA -39
reverse 59- CCCCACCTTGATATCCCAGG -39
Collagen IV (a1) forward 59- AACGAAAGGGACACGAGGA -39
reverse 59- GGCCAGGAATACCAGGAAGT -39
Fibronectin forward 59- TTGCAACCCACCGTGGAGTATGTG -39
reverse 59- CTCGGTAGCCAGTGAGCTTAACAC -39
TIMP-2 (Tissue Inhibitor of Metalloproteases-2) forward 59- GCTGGACGTTGGAGGAAAGA -39
reverse 59- GCACAATAAAGTCACAGAGGGTAAT -39
probe 59(FAM)- TCTCCTTCCGCCTTCCCTGCAATTAGA -(TAMRA)39
18S forward 59- TTGATTAAGTCCCTGCCCTTTGT -39
reverse 59- CGATCCGAGGGCCTCACTA -39
probe 59(FAM)- CGCCCGTCGCTACTACCGATTGG -(TAMRA)39
Designed SYBR Green primer pairs and primer pairs and TaqMan probes used in this study.
doi:10.1371/journal.pone.0020369.t001
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of the obtained values was documented.
Additionally in the same animals, intra-arterial blood pressure
measurements were performed. 70 day old rats were anesthesized
with 20 mg/kg ketamine (Ketavet, Pfizer GmbH) and 0.5 mg/kg
medetomidin (Domitor, Pfizer GmbH) by intraperitoneal appli-
cation. Catheters were implanted in the right femoral artery and
tunneled subcutaneously. Animals were antagonized with 0.2 ml
atipamezol (5 mg/ml, Antisedan, Pfizer GmbH) and woke up
within 3–5 minutes. After a recovery phase of 2 hours mean
arterial blood pressure was recorded by a polygraph (Hellige,
Freiburg, Germany) in conscious animals for 30 minutes.
In order to confirm the data obtained from our non-invasive and
invasive measurements, telemetric blood pressure measurements
were performed in additional animals derived from two different
litters in each group. Telemetry transmitters (TA11PA-C40, Data
Figure 1. Body and relative heart weights. A: Birth weights, B:
body weights at day 70 of life and C: relative heart weights at day 70 of
life of rats with intrauterine growth restriction (LP) and their respective
controls (NP). Data are means6sem.
doi:10.1371/journal.pone.0020369.g001
Figure 2. Telemetric blood pressure measurements. Systolic (A),
diastolic (B) and mean arterial (C) blood pressure values of two IUGR-
rats (LP) and two controls (NP) at the age of 70 days of life obtained by
telemetric measurements for one week. Data are means 6 sem.
doi:10.1371/journal.pone.0020369.g002
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After seven days of postinterventional recovery, blood pressure and
heart rate were documented for one week.
Immunohistochemistry
Vascular and ventricular paraffin sections were layered with the
primary antibody, and incubated at 4uC overnight. After addition
of the secondary antibody (dilution 1:500; biotin-conjugated, goat
anti-rabbit IgG or rabbit anti-mouse IgG, all from Dianova,
Hamburg, Germany), the staining procedures were carried out by
a peroxidase detection method as described before [23]. Each slide
was counterstained with hematoxylin. As a negative control, we
used equimolar concentrations of preimmune rabbit or mouse
immunoglobulin G. To detect macrophages, sections were stained
with a monoclonal antibody to ED-1 in a dilution of 1:250
(Serotec, Biozol, Eching, Germany), proliferating cells were
stained with a monoclonal antibody to PCNA in a dilution of
1:50 (DAKO, Hamburg, Germany). Smooth muscle actin was
detected with a monoclonal antibody (1:50) from Serotec (Biozol).
The antibody to osteopontin was used as described [23]. The
primary rabbit antibody to collagen I was from Biogenesis (Poole,
England) and used at a dilution of 1:1000. The rabbit polyclonal
antibody to collagen IV was used at a dilution 1:500 (Southern
Biotechnology Associates, Birmingham, AL, USA). Counting of
proliferating cells and macrophages was performed after staining.
In vascular tissue, all ED-1 or PCNA-positive cells per cross
section were counted. In the heart, ED-1 or PCNA-positive cells
were counted in five to ten myocardial views per section.
Expansion of smooth muscle actin, collagen I and IV staining in
the media or in the myocardium was evaluated in a Leitz
Aristoplan microscope (Leica Instruments) by Metaview software
(Visitron Systems, Puchheim, Germany). The stained area was
expressed as percentage of the total medial area.
Real time RT-PCR
Vascular or myocardial tissue (10 mg) was homogenized in
500 ml of RLT buffer reagent (Qiagen, Hilden, Germany) with an
ultraturrax for 30 seconds, and total RNA was extracted from
homogenates with RNeasy Mini columns (Qiagen) according to
the standard protocol. First-strand cDNA was synthesized with
TaqMan reverse transcription reagents (Applied Biosystems,
Darmstadt, Germany) using random hexamers as primers. The
final RNA concentration in the reaction mixture was adjusted to
0.1 ng/mL. Reactions without Multiscribe reverse transcriptase
Table 2. Markers of cell growth and differentiation.
Age neonatal day 70
Diet NP LP NP LP
Aorta:
Cell proliferation (% PCNA-positive cells/
media cross section)
79.8962.68 71.5161.48 3.2560.51 1.8860.95
a-smooth muscle actin (% medial area) 80.2962.72 73.4161.84 45.7461.94 51.7464.67
Heart:
Cell proliferation (PCNA-positive cells/
myocardial view)
96.8564.17 120.2662.15* 9.1860.32 7.2860.89
Cell proliferation and areas of medial a-smooth muscle actin stain in aortas and hearts of neonatal rats and of rats at day 70 of life with intrauterine growth restriction
(LP) or controls (NP).
*p,0.05 versus NP.
doi:10.1371/journal.pone.0020369.t002
Table 3. Markers of inflammation.
Age neonatal day 70
Diet NP LP NP LP
Aorta:
Macrophage infiltration (ED-1-positive cells/cross
section)
0.1560.12 0.4460.26 0.0060.00 0.0160.01
MCP-1 expression (fold induction) 0
a 0
a 0
a 0
a
Osteopontin expression (fold induction) 0
a 0
a 0
a 0
a
Heart:
Macrophage infiltration (ED-1-positive cells/
myocardial view)
16.0162.23 11.2560.90* 4.2561.07 5.3662.93
MCP-1 expression (fold induction) 1.0060.14 0.7060.34 1.0060.54 6.1163.07
Osteopontin expression (fold induction) 1.0060.28 1.2660.41 1.0060.50 7.1962.60*
Macrophage infiltration and expression of the chemotactic peptides MCP-1 and osteopontin in aortas and hearts of neonatal rats and in rats at day 70 of life with
intrauterine growth restriction (LP) or controls (NP).
aIn aortas, MCP-1 and osteopontin expression were below detection limits.
*p,0.05 versus NP.
doi:10.1371/journal.pone.0020369.t003
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RT-products were diluted 1:1 with dH2O before PCR procedure.
PCR was performed with an ABI PRISM 7000 Sequence
Detector System and SYBR Green or TaqMan reagents (Applied
Biosystems) according to the manufacturers instructions. Primers
used for real-time RT-PCR are listed in table 1. Primer pairs and
probes were designed using Primer Express software (Perkin
Elmer, Foster City, CA, USA), except for transforming growth
factor-b (TGF-b) [24], collagen I [25], tissue inhibitor of
metalloproteases-1 (TIMP-1) [26], osteopontin [27] and monocyte
chemoattractant protein-1 (MCP-1) [28]. All samples were run in
triplicates. Specific mRNA levels were calculated and normalized
to 18S rRNA as a housekeeping gene with the DDCT method as
specified by the manufacturer (http://www3.appliedbiosystems.
com/cms/groups/mcb_support/documents/generaldocuments/
cms_040980.pdf).
Western blot analysis
From aortas of 7 newborn control and 7 IUGR rats connective
tissue was carefully removed. Aortas were homogenized in a buffer
containing 50 mM Tris HCl, pH 7.5, 1% Triton X-100, 0.1%
deoxycholic acid, 0.1% SDS, 150 mM NaCl, 1 mM PMSF,
1 mM sodium vanadate, 14 mg/ml aprotinin. Protein concentra-
tion was determined using a protein assay kit (Pierce, Rockford,
IL, USA). Protein samples were denatured by boiling for five
minutes in Laemmli sample buffer and separated on a 10%
denaturing SDS-PAGE gel. After electrophoresis, the gels were
electroblotted onto PVDF membranes (Hybond-P, GE Amer-
sham, Munich, Germany), blocked with Rotiblock (Roth,
Karlsruhe, Germany) for 1 hour and incubated overnight with a
polyclonal antibody to CTGF (SC14939, Santa Cruz, Heidelberg,
Germany) in a concentration of 1:500. CTGF was visualized with
a secondary horseradish peroxidase-conjugated anti-goat IgG
antibody (Santa Cruz, 1:50000), using the ECL system (GE
Amersham). Blots were quantified using a luminescent imager
(LAS-1000, Fujifilm, Berlin, Germany) and Aida 2.1 image
analysis software (Raytest, Berlin, Germany). Loading of the blot
was quantified by reprobing with an antibody to tubulin (Sigma,
Taufkirchen, Germany, 1:10000), which was detected with a
secondary horseradish peroxidase-conjugated anti-mouse IgG
antibody (GE Amersham, Munich,Germany, 1:10000).
Analysis of data
Animals from 6 litters per group were used when neonate tissue
was investigated. Animals from 5 litters per group were used when
tissue from day 70 of life was investigated. Data were weighted for
litter. All data are expressed as means 6 standard error of the
mean. Student’s t-test was used to assess the differences between
the groups. Our study was designed for comparisons between
IUGR and control rats but not for comparisons between neonatal
and d70 animals. Hence, 2-way analysis of variance was not
performed. Results were considered significant when the proba-
bility of error (p) was less than 0.05.
Results
Low protein diet in the pregnant dams led to a significant
reduction of birth weights of their offspring (figure 1A). Some
degree of catch up growth was observed in the protein restricted
offspring (LP). However, at day 70 of life, body weights of LP
animals were still reduced compared to the body weights of the
control group (NP) (figure 1B). Relative heart weights at day 70 of
life were comparable in NP and LP (figure 1C). Systolic blood
pressure was comparable in the LP and NP group as assessed by
tail cuff blood pressure measurements performed in 70 days old
rats (134.567.03 mmHg in NP versus 127.365.03 mmHg in LP,
n.s.). Moreover, intraarterial blood pressure recordings revealed
no differences in mean arterial blood pressure levels of NP and LP
rats at this age (105.364.63 mmHg in NP versus 101.36
7.12 mmHg in LP, n.s.). These findings were confirmed by
telemetric blood pressure measurements in two rats of each
experimental group from day 70 for one week (Figure 2).
In the aortas and hearts of neonate and 70 days old LP and NP
rats, parameters of cell proliferation and differentiation (PCNA
and a-smooth muscle actin), inflammation (macrophage infiltra-
tion, expression of chemotactic factors) and fibrosis (expression of
profibrotic cytokines, expression and deposition of extracellular
matrix molecules) were assessed.
Cell proliferation and differentiation
In aortas of neonate LP rats, cell proliferation, as assessed by
PCNA staining, occurred frequently but was not different to aortas
of NP controls (table 2). At day 70 of life, cell proliferation rates in
aortas were much lower compared to neonates (table 2), but again
no significant differences between LP and NP rats were detected
(p=0.36; table 2). In contrast to the findings in aortas, cell growth
in heart tissue seemed to be regulated by maternal protein diet:
Myocardial cell proliferation rates were higher in LP than in NP
neonates (table 2). In the heart tissue at day 70 of life, cell
proliferation occurred less frequently than in neonate hearts, with
a tendency to a reduced proliferation rate in LP compared to NP
rat hearts (p=0.08; table 2). As a vascular cell differentiation
marker we investigated a-smooth muscle actin. Smooth muscle
cell differentiation does not seem to be influenced by maternal
protein diet: The extent of a-smooth muscle actin staining in
aortas was not significantly altered in LP and NP rats at the time of
birth (p=0.06) and at day 70 of life (table 2).
Figure 3. Examples of myocardial stainings for osteopontin.
Representative photomicrographs of immunostainings for osteopontin
(OPN) in myocardial tissue of neonatal control rats and neonatal rats
with intrauterine growth restriction (neo); and in myocardial tissue of
control rats and rats with intrauterine growth restriction at day 70 of life
(d70). NP, control rats; LP, rats with intrauterine growth restriction.
Arrow indicates positive immunoreactivity for OPN in the media of
myocardial vessels in LP at day 70.
doi:10.1371/journal.pone.0020369.g003
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In order to study possible differences in the inflammatory
response of LP and NP rats, we performed expression analyses of
inflammation markers and studied macrophage infiltration in
aortas and hearts of newborn rats and rats at day 70 of life.
Macrophage infiltration into the aortas of newborn and 70 days
old rats occurred very rarely and was comparable in LP and NP
rats (table 3). In contrast, macrophage infiltration in the
myocardium was reduced in the LP neonates (table 3) while at
day 70 of life, myocardial macrophage infiltration was not
different between NP and LP animals anymore (table 3). In the
aortas of neonate rats and of rats at day 70 of life, the mRNA levels
of the chemokines MCP-1 and osteopontin were below detection
limits and therefore were not further evaluated. In the hearts of
neonate LP rats, MCP-1 and osteopontin expression was not
significantly different from NP animals (table 3). At day 70 of life,
myocardial MCP-1 expression tended to be higher in LP than in
NP rats. However, due to the large variability in LP rats, this
increase did not reach statistical significance (p=0.14; table 3). In
contrast, the expression of osteopontin was significantly augment-
ed in the hearts of 70 days old LP rats compared to NP rats
(table 3). In order to localize the tissue compartment responsible
for the increase in osteopontin expression, immunohistochemistry
for osteopontin in the myocardium was performed. While in
neonate heart tissue no differences in staining patterns between NP
and LP rats were observed (figure 3), osteopontin immunohisto-
chemistry in the hearts of rats at day 70 of life revealed a distinct
staining of the media of myocardial vessels in LP animals which
was not detected in NP animals (figure 3).
Fibrosis
The expression of two profibrotic cytokines, TGF-b and CTGF,
was studied. While TGF-b expression was the same in neonate
aortas of LP and NP rats (table 4), CTGF mRNA expression was
significantly higher in neonate aortas of LP rats compared to NP
rats (table 4). This was also reflected on the protein level: Western
blot analysis revealed increased CTGF protein expression in
neonate aortas of LP rats compared to NP rats (figure 4A+B). At
day 70 of life, the aortal expression of TGF-b was still similar in
both experimental groups (table 4), while due to a high variability
in LP rats the expression of CTGF only revealed a tendency to be
increased in LP (p=0.06; table 4). In contrast to the findings in
aortas, similar neonatal changes were not observed in myocardial
tissue of LP rats: In the hearts of neonate rats, no differences in the
expression levels of the profibrotic cytokines TGF-b and CTGF
were detected between LP and NP (table 4). At day 70 of life,
however, the myocardial expression of both TGF-b and CTGF
was augmented in LP (table 4). Subsequently, we evaluated the
Table 4. Markers of fibrosis.
Age neonatal day 70
Diet NP LP NP LP
Aorta:
TGF-b expression (fold induction) 1.0060.29 1.0760.30 1.0060.59 1.0460.20
CTGF expression (fold induction) 1.0060.18 3.1960.87* 1.0060.31 4.0161.35
LTBP-1 expression (fold induction) 1.0060.13 0.9360.13 1.0060.32 0.5060.10
Fibrillin-1 expression (fold induction) 1.0060.20 1.0760.19 1.0060.26 3.0460.90
Elastin expression (fold induction) 1.0060.16 0.8060.19 1.0060.18 1.9560.79
Fibronectin expression (fold induction) 1.0060.29 1.0760.30 1.0060.24 6.3663.02
Collagen I expression (fold induction) 1.0060.17 1.2260.25 1.0060.52 5.5562.03*
Collagen I (% stained/medial area) 1.7760.40 1.6760.23 1.4760.12 2.1860.34
Collagen IV expression (fold induction) 1.0060.39 1.7360.87 1.0060.31 1.2560.28
Collagen IV (% stained/medial area) 3.5760.43 2.9560.51 8.0860.41 10.3660.85*
TIMP-1 expression (fold induction) 1.0060.14 1.1360.18 1.0060.69 0.9460.37
TIMP-2 expression (fold induction) 1.0060.27 0.9560.22 1.0060.20 5.2062.00
Heart:
TGF-b expression (fold induction) 1.0060.12 1.1060.39 1.0060.33 3.6960.84*
CTGF expression (fold induction) 1.0060.24 0.4460.16 1.0060.32 5.4760.92*
LTBP-1 expression (fold induction) 1.0060.17 0.6660.15 1.0060.40 3.5960.63*
Fibrillin-1 expression (fold induction) 1.0060.16 0.6260.14 1.0060.449 4.5560.65*
Elastin expression (fold induction) 1.0060.53 0.3460.12 1.0060.43 5.7061.35*
Fibronectin expression (fold induction) 1.0060.28 0.8160.30 1.0060.46 7.1261.53*
Collagen I expression (fold induction) 1.0060.35 0.8460.34 1.0060.55 6.3861.32*
Collagen IV expression (fold induction) 1.0060.08 0.9160.14 1.0060.21 4.0760.22*
TIMP-1 expression (fold induction) 1.0060.07 0.9060.23 1.0060.56 4.2562.07
TIMP-2 expression (fold induction) 1.0060.11 0.7660.22 1.0060.43 7.3861.58*
mRNA expression of markers of fibrosis and type I and IV collagen stain in aortas and hearts of neonatal rats and in rats at day 70 of life with intrauterine growth
restriction (LP) or controls (NP).
*p,0.05 versus NP.
doi:10.1371/journal.pone.0020369.t004
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expression levels of the microfibrillar matrix proteins LTBP-1,
fibrillin-1 and elastin did not reveal any significant differences in
aortas of neonate NP and LP as well as in NP and LP at day 70 of
life. In myocardial tissue of neonate NP and LP rats, the
expression of microfibrillar matrix proteins did not vary
significantly (p=0.17 for LTBP; p=0.10 for fibrillin-1 and
p=0.28 for elastin; table 4). At day 70 of life, however, the
expression of microfibrillar matrix proteins was 3 to 5-fold
increased in the myocardium of LP rats (figure 4). Evaluation of
the expression patterns of fibronectin revealed no differences in the
aorta of newborn rats, but a tendency to more aortal fibronectin
expression at day 70 of life (p=0.052; table 4). In the hearts of
newborn LP rats, no increase in fibronectin expression was
observed, but at day 70 of life fibronectin expression was
augmented in the hearts of LP rats (table 4). Collagen I and IV
expression and deposition was not different in the aortas of
neonate NP and LP rats (table 4). At day 70 of life, an increase in
collagen I expression and a tendency to more collagen I deposition
(p=0.07) and more collagen IV deposition was observed in LP
rats (table 4). Moreover, myocardial collagen I and IV expression
and deposition, although not altered in neonate LP rats, were all
increased at day 70 of life (table 4, figures 5 and 6). Finally,
evaluation of the aortal expression levels of two regulators of
matrix turnover, TIMP-1 and TIMP-2 did not reveal any
significant differences in neonate NP and LP rats nor at day 70
of life (table 4). At day 70 of life, only a tendency towards an
increased expression of TIMP-2 was observed in aortas of LP
animals (p=0.053; table 4). In the hearts of LP rats, solely the
expression of TIMP-2 was significantly higher than of NP rats at
day 70 of life (figure 4), while the expression of TIMP-1 merely
revealed a trend to be increased in the hearts of LP rats at day 70
of life (p=0.17) due to a high variability in expression levels
(table 4).
Discussion
The salient finding of our study is the presence of changes in the
expression patterns of profibrotic genes, and of discrete structural
abnormalities of vessels and hearts in adolescence, in the low
protein diet model of IUGR despite normal blood pressure at the
time point investigated. IUGR is often associated with hyperten-
sion later in life [17,29], which might lead to cardiovascular
changes similar to those observed. In our animal model of IUGR,
however, blood pressure was not yet increased in IUGR at the
time points we studied. Thus, it seems conceivable that changes in
aortal and myocardial tissue in our study are not the secondary
result of hypertension, but the potential primary precursors of
cardiovascular disease following IUGR.
IUGR is considered as the consequence of a disturbed
intrauterine environment. Therefore, a variety of animal models
exist to induce IUGR e.g. maternal protein restriction [30],
maternal exposure to hypoxia [31] or the arteriae uterinae ligation
model [32]. These models may to some extent reflect the different
factors which can bring about IUGR in humans in different
clinical situations, such as nutritional deficiencies or placental
hypoperfusion, respectively [33]. For example, the hypoxic models
lead to hypoxia of the placenta and the fetus without impairing the
maternal metabolic and endocrinologic status [33]. On the other
hand, surgical models best represent placental hypoperfusion but
may entail unwanted side effects by the necessary operative
intervention. Even a sham operation at this stage of pregnancy, or
the necessary anaesthesia, may affect the growth of the fetus [34].
Our findings are limited to the protein restriction model in rats.
Protein restriction is presumably not a major factor causing IUGR
in developed countries. However, the effects of maternal protein
restriction on the fetus are not limited to an isolated nutritional
defect. Data from various animal studies suggest that maternal
protein restriction affects placental size, one of the major
indicators of placental insufficiency [35], and alters placental
vasculature and the exchange barrier [36,37]. Despite its
limitations, the animal model of maternal protein restriction used
in this study thus comprises both fetal hypoxia and nutrient
restriction. On the other hand one has also to face the
disadvantages of this animal model: The outcome varies between
the species and the composition of the nutrition used [2]. Other
central aspects like the timing and the duration of protein
restriction as well as maternal metabolic status have to be
standardized to obtain reproducible results. The absence of
hypertension is both a strength and a limitation of our study.
We presume that the vascular and myocardial changes observed
by us would be further aggravated by hypertension but we did not
test this hypothesis. Hypertension may be present early in other
models of IUGR such as uterine ligation [38] and may occur later
in life in the protein restriction model [39]. We did rule out
hypertension in the time period investigated, in agreement with a
recent study [40], reporting radiotelemetric blood pressure results
from slightly older IUGR animals in the protein restriction model.
Our study was designed for comparisons between IUGR and
control rats but not for direct comparisons between neonatal and
Figure 4. Aortal CTGF expression. A: Protein expression of
connective tissue growth factor (CTGF) in aortas of newborn rats with
intrauterine growth restriction (LP, n=4) and their respective controls
(NP; n=5). Data are means 6 sem. B: Example of Western blot analysis
detecting connective tissue growth factor (CTGF). Tubulin was used as a
loading control.
doi:10.1371/journal.pone.0020369.g004
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example, animals from the d70 time point were from different
litters than animals for the neonatal time point, and the molecular
expression data for the different time points were not assayed
together.
We detected an increased expression of connective tissue growth
factor (CTGF) in aortas of IUGR neonates and an increased
vascular expression and deposition of collagens in former IUGR
rats at day 70 of life. CTGF is a growth factor involved in fibrotic
changes in several organs, including blood vessels [41]. As CTGF
Figure 5. Myocardial deposition of collagen I. Evaluation of the percentage of positive immunostaining for collagen I (coll I) in myocardial tissue
of (A) neonatal control rats and neonatal rats with intrauterine growth restriction (neo) with representative photomicrographs; and in myocardial
tissue of (B) control rats and rats with intrauterine growth restriction at day 70 of life (d70) with representative photomicrographs. NP, control rats; LP,
rats with intrauterine growth restriction. Data are means 6 sem.
doi:10.1371/journal.pone.0020369.g005
Figure 6. Myocardial deposition of collagen IV. Evaluation of the percentage of positive immunostaining for collagen IV (coll IV) in myocardial
tissue of (A) neonatal control rats and neonatal rats with intrauterine growth restriction (neo) with representative photomicrographs; and in
myocardial tissue of (B) control rats and rats with intrauterine growth restriction at day 70 of life (d70) with representative photomicrographs. NP,
control rats; LP, rats with intrauterine growth restriction. Data are means 6 sem.
doi:10.1371/journal.pone.0020369.g006
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humans [43] and is undetectable in normal human blood vessels
[43], it is thought to contribute to atherogenesis. CTGF can
stimulate the production of matrix molecules, like collagen I and
fibronectin [44], and induce mononuclear cell chemotaxis [45] as
well as vascular smooth muscle cell growth and migration [46].
One might speculate that the early expression of CTGF in the
aorta in IUGR neonates could consequently lead to the observed
vascular overexpression of collagens later in life. If CTGF can also
induce the expression of fibrillin-1, however, is unknown. CTGF is
also regarded as a central factor regulating angiogenesis [47] and
myocardial development [48]. However, in the neonatal heart of
IUGR rats, no myocardial CTGF upregulation was observed,
indicating that the observed aortic CTGF upregulation is a
structure specific IUGR-induced change.
Although no gross alterations in aortic histology were observed,
a consistent high expression of matrix molecules might result in
more overt vascular changes later in life. In humans, the aortic
wall of IUGR newborns was found to be thicker than in newborns
with normal birth weight, although there was an extensive overlap
[14]. Moreover, alterations in the composition of the vascular
extracellular matrix could possibly reduce the elastic properties of
the vessels and thus reduce vascular compliance, which is known
to be a marker of cardiovascular disease. A shift in the relative
amounts of collagen and elastin was already suggested by Martyn
et al. [11] for human fetal aortas of individuals with low birth
weight. This notion is supported by our data on changes in
collagen expression levels while we could not show significant
alterations in the expression of elastin in aortas of IUGR neonatal
rats nor at day 70 of life.
In the hearts of neonatal IUGR rats, no profibrotic changes
were observed in our study. However, myocardial cell proliferation
was augmented in neonate IUGR rats. In contrast, Corstius et al.
demonstrated a reduced number of cardiomyocytes in the hearts
of neonate female rats in response to low protein diet [19]. Four
weeks later, however, the number of cardiomyocytes was not
different anymore in this model, as shown by the same group [49].
Thus, the augmented myocardial cell proliferation in neonate rats
after IUGR described in our study might indicate a compensatory
postnatal hyperplasia following an initially reduced number of
cardiomyocytes. But this early myocardial remodelling might also
trigger the development of fibrotic alterations later in life. In this
context Lim et al. could show that former IUGR animals
developed increased interstitial fibrosis of the left ventricle,
suggesting that an early dysregulation of cardiomyocyte prolifer-
ation and subsequent cellular hypertrophy might result in
increased accumulation of collagens at a higher age [20].
However, in this study it remained unclear, if the higher incidence
of fibrosis in the left ventricle could also be a consequence of an
increased blood pressure. In accordance to this study and to others
in different animal models of IUGR [50,51] we detected an
increased expression and accumulation of collagens in the hearts
of former IUGR individuals later in life.
Furthermore we could show an overexpression of all matrix
molecules investigated, even of those known to serve elastic
properties like elastin or fibrillin-1. The functional consequences of
an overexpression of these molecules in heart tissue are not known
[52], but Bouzeghrane et al. observed an enhanced deposition of
fibrillin-1 in the fibrotic hearts of rats suffering from hypertensive
disease [53], arguing for a role for fibrillin-1 in myocardial fibrosis.
This could also be accelerated by higher expression levels of tissue
inhibitor of metalloprotease 2 (TIMP-2), which was seen at day 70
of life in our study. TIMP-2 serves as a potent inhibitor of matrix
degradation [54].
There is growing evidence for an altered immune response in
IUGR individuals [22,33]. Surprisingly, macrophage infiltration
into the myocardium was lower in newborn IUGR rats than in
control rats in our study, while at day 70 of life former IUGR rats
tended to exhibit increased macrophage infiltration. This went
along with an increased expression of the chemotactic protein
osteopontin (OPN). OPN is a multifunctional molecule which also
regulates macrophage associated inflammatory pathways [55].
Clinical studies proved an increased myocardial expression of
OPN in acute as well as chronic heart disease, like myocardial
infarction [56] or dilated cardiomyopathy [57]. Furthermore there
is growing evidence that OPN is a valid predictor for the outcome
of patients with chronic heart disease [58] and contributes to
fibrotic myocardial remodeling [59].
Taken together, our data support the hypothesis that subtle but
defined molecular and structural changes develop in IUGR before
the manifestation of cardiovascular risk factors like arterial
hypertension, at least in our rat model of protein restriction.
These alterations may in turn predispose to cardiovascular disease
later in life by increasing the vascular and cardiac vulnerability to
additional stressors or risk factors.
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